CREDIT SUISSE AG/ - MADRIGAL PHARMACEUTICALS INC ownership

MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 207 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.38 and the average weighting 0.3%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of MADRIGAL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,562,628
-51.8%
10,700
-23.8%
0.00%
-33.3%
Q2 2023$3,245,319
+27.7%
14,049
+33.9%
0.00%0.0%
Q1 2023$2,541,307
-12.5%
10,490
+4.8%
0.00%0.0%
Q4 2022$2,904,241
+343.4%
10,006
-0.6%
0.00%
+200.0%
Q3 2022$655,000
+8.1%
10,068
+18.8%
0.00%0.0%
Q2 2022$606,000
-24.6%
8,473
+3.4%
0.00%0.0%
Q1 2022$804,000
+42.6%
8,194
+23.2%
0.00%
Q4 2021$564,000
-8.3%
6,653
-13.7%
0.00%
Q3 2021$615,000
+2.3%
7,712
+25.1%
0.00%
Q2 2021$601,000
-43.0%
6,166
-31.7%
0.00%
-100.0%
Q1 2021$1,055,000
-36.7%
9,022
-39.8%
0.00%0.0%
Q4 2020$1,667,000
+36.9%
14,992
+46.2%
0.00%0.0%
Q3 2020$1,218,000
-51.8%
10,253
-54.0%
0.00%
-50.0%
Q2 2020$2,525,000
+192.6%
22,296
+72.4%
0.00%
+100.0%
Q1 2020$863,000
-56.5%
12,933
-40.7%
0.00%0.0%
Q4 2019$1,986,000
+172.4%
21,798
+157.6%
0.00%0.0%
Q3 2019$729,000
+6.1%
8,463
+29.1%
0.00%0.0%
Q2 2019$687,000
-21.1%
6,556
-5.9%
0.00%0.0%
Q1 2019$871,000
+9.0%
6,966
-1.7%
0.00%0.0%
Q4 2018$799,000
-35.0%
7,089
+23.5%
0.00%0.0%
Q3 2018$1,230,000
-50.0%
5,740
-34.7%
0.00%
-50.0%
Q2 2018$2,459,000
+263.2%
8,788
+51.7%
0.00%
+100.0%
Q1 2018$677,000
+46.5%
5,793
+15.0%
0.00%
Q4 2017$462,0005,0360.00%
Other shareholders
MADRIGAL PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
HealthCor Management, L.P. 1,402,250$93,614,0004.00%
Parkman Healthcare Partners LLC 30,000$2,003,0000.93%
ARMISTICE CAPITAL, LLC 216,000$14,420,0000.89%
Avoro Capital Advisors LLC 349,000$23,299,0000.79%
Rock Springs Capital Management LP 250,000$16,690,0000.69%
Capital Impact Advisors, LLC 24,351$1,626,0000.68%
Baker Brothers Advisors 1,499,212$100,087,0000.62%
EWG Elevate Inc. 11,086$740,0000.56%
SHIKIAR ASSET MANAGEMENT INC 12,000$801,0000.54%
DAFNA Capital Management LLC 13,600$908,0000.38%
View complete list of MADRIGAL PHARMACEUTICALS INC shareholders